Diabetic patients have a defect in their ability to heal wounds and respond to ischemic stress. The mechanisms responsible for this compromised vascular regenerative capacity are poorly understood. Recently, endothelial precursor cells (EPCs) have been recognized to be recruited to sites of neovascularization. Preliminary work in our laboratory shows that diabetic mice (db/db, NOD, and streptozotocin-induced) are specifically deficient, compared to normal control mice, in their ability to mobilize and recruit endothelial precursor cells (EPCs) to wounds or ischemic limbs. An essential role for EPC recruitment in normal mice impairs both wound healing and the response to acute ischemia. This dysfunctional regenerative neovascularization in diabetic mice can be corrected by adenoviral-mediated overexpression of angiogenic growth factors, such as Angiopoietin-1 (Ang-1) which recruit EPCs that can correct diabetic wound healing impairment and the poor response to ischemia. The overall objective of our investigations is to understand the mechanisms by which EPCs are mobilized and recruited to target tissues in wound healing and in response to ischemia and understand how these mechanisms are impaired by diabetes. Our working hypothesis is that recruitment of bone marrow-derived EPCs is essential for triggering a rapid neovascularization response in a wound or ischemic tissue and that site-specific EPC recruitment is specifically deficient in diabetes. In order to test this hypothesis we plan experiments to achieve the following specific aims: 1. To demonstrate that mobilization and recruitment of growth factors 2. To determine the mechanism by which angiogenic growth factors mobilize and recruit bone marrow-derived EPCs to target areas of a wound or ischemic tissues 3. To determine the mechanisms by which EPCs orchestrate the local angiogenic response by interaction with resident cellular milieu.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK072446-03
Application #
7258399
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Jones, Teresa L Z
Project Start
2005-08-01
Project End
2009-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
3
Fiscal Year
2007
Total Cost
$291,566
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Balaji, Swathi; Han, Nate; Moles, Chad et al. (2015) Angiopoietin-1 improves endothelial progenitor cell-dependent neovascularization in diabetic wounds. Surgery 158:846-56
Keswani, Sundeep G; Balaji, Swathi; Katz, Anna B et al. (2015) Intraplacental gene therapy with Ad-IGF-1 corrects naturally occurring rabbit model of intrauterine growth restriction. Hum Gene Ther 26:172-82
Keswani, Sundeep G; Balaji, Swathi; Le, Louis D et al. (2013) Role of salivary vascular endothelial growth factor (VEGF) in palatal mucosal wound healing. Wound Repair Regen 21:554-62
Keswani, Sundeep G; Balaji, Swathi; Le, Louis et al. (2012) Pseudotyped AAV vector-mediated gene transfer in a human fetal trachea xenograft model: implications for in utero gene therapy for cystic fibrosis. PLoS One 7:e43633
Balaji, Swathi; Vaikunth, Sachin S; Lang, Stephanie A et al. (2012) Tissue-engineered provisional matrix as a novel approach to enhance diabetic wound healing. Wound Repair Regen 20:15-27
Keswani, Sundeep G; Balaji, Swathi; Le, Louis et al. (2012) Pseudotyped adeno-associated viral vector tropism and transduction efficiencies in murine wound healing. Wound Repair Regen 20:592-600
Morris, Lee M; Klanke, Charles A; Lang, Stephanie A et al. (2010) Characterization of endothelial progenitor cells mobilization following cutaneous wounding. Wound Repair Regen 18:383-90
Maldonado, Arturo R; Klanke, Chuck; Jegga, Anil G et al. (2010) Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors. J Gene Med 12:613-23
Mahller, Yonatan Y; Vaikunth, Sachin S; Ripberger, Maria C et al. (2008) Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors. Cancer Res 68:1170-9
Parvadia, Jignesh K; Keswani, Sundeep G; Vaikunth, Sachin et al. (2007) Role of VEGF in small bowel adaptation after resection: the adaptive response is angiogenesis dependent. Am J Physiol Gastrointest Liver Physiol 293:G591-8